Page 124 - Critical Care Notes
P. 124

4223_Tab03_107-130  29/08/14  8:28 AM  Page 118



                        RESP
          Diagnostic Tests
          ■ CXR
          ■ ABGs and/or pulse oximetry
          ■ ECG
          ■ Plasma BNP level
            ■ Normal level: 34–42 pg/mL (11.0–13.6 pmol/L)
          ■ Serum cardiac markers
          ■ Two-dimensional transthoracic echocardiogram
          ■ Transesophageal echocardiogram
          Management
          ■ Maintain sitting position if BP reading permits.
          ■ Start IV and obtain ABGs.
          ■ Administer O 2 of 5–6 L/min by simple face mask or 1–15 L/min by nonre-
            breather mask with reservoir. Consider BiPaP or CPAP. Keep SpO 2 >90%.
          ■ Increase O 2  concentration if needed. If unable to resolve respiratory distress,
            persistent hypoxemia, and acidosis, intubation or mechanical ventilation is
            needed. Consider PEEP.
          ■ Monitor patient with cardiac monitor and pulse oximetry.
          ■ If systolic BP >100, administer nitroglycerin.
          ■ Administer diuretics: IV furosemide (Lasix) 0.5–1 mg/kg. Restrict fluids.
          ■ Administer morphine slowly if BP is stable. Questionable use to decrease
            preload.
          ■ Administer vasodilators and/or inotropes (dopamine, dobutamine, norepi-
            nephrine, milrinone), preload (NTG, diuretics, morphine, nesiritide) or after-
            load agents (ACE inhibitors, nitroprusside), and contractility medications as
            indicated.
          ■ Consider intra-aortic balloon pumping.
          ■ Consider ultrafiltration if evidence of renal dysfunction or diuretic resistance.
          ■ Treat the underlying cause.
           Pulmonary Arterial Hypertension (PAH) Cor Pulmonale
          PAH is defined as mean pulmonary artery pressure (PAP m ) ≥25 mm Hg and
          PCWP  ≤15 mm Hg as measured by cardiac catheterization, with a resultant
          increased pulmonary vascular resistance.
           Cor pulmonale is RV hypertrophy or failure resulting from pulmonary hyperten-
          sion, massive pulmonary embolism, and other pulmonary/pulmonary vascular
          conditions. Living at high altitudes can also cause this condition.
          Pathophysiology
          PAH is seen in preexisting pulmonary or cardiac disease, LVF, familial pulmonary
          or cardiac disease, COPD, obesity, alveolar hypoventilation, smoke inhalation, high
          altitude, collagen vascular disease, vasoconstriction of pulmonary bed resulting
                                118
   119   120   121   122   123   124   125   126   127   128   129